in comparing the observed toxicities in 1,434 treatment cycles , there was a significant difference with regard to leukocytopenia ( mitoxantrone arm exhibiting more than either epirubicin and doxorubicin ) although infections did not occur more frequently in the mitoxantrone arm ;
C0014582
epirubicin
C0013089
doxorubicin